ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc (SNOA)

1,15
0,00
(0,00%)
Geschlossen 21 Juni 10:00PM
1,1588
0,0088
(0,77%)
Nach Börsenschluss: 1:59AM

Sonoma Pharmaceuticals Inc (SNOA) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
1,1588
( 0,77% )
Gebot
1,11
Fragen
1,23
Volumen
76.475
1,10 Tagesbereich 1,18
0,8501 52-Wochen-Bereich 6,9199
Marktkapitalisierung
Handelsende
1,15
Handelsbeginn
1,15
Letzte Trade
65
@
1.11
Letzter Handelszeitpunkt
Finanzvolumen
US$ 86.425
VWAP
1,1301
Durchschnittliches Volumen (3 Mio.)
US$ 198.671
Ausgegebene Aktien
3.473.554
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,53
Gewinn pro Aktie (EPS)
-2,04
Erlöse (LTM)
17,72M
Nettogewinn (LTM)
-3,37M

Über Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin t... Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Boulder, United States
Gegründet
1999
Sonoma Pharmaceuticals Inc is listed in the Healthcare sector of the NASDAQ with ticker SNOA. The last closing price for Sonoma Pharmaceuticals was US$1,15. Over the last year, Sonoma Pharmaceuticals shares have traded in a share price range of US$ 0,8501 to US$ 6,9199.

Sonoma Pharmaceuticals currently has 3.473.554 shares in issue. The market capitalisation of Sonoma Pharmaceuticals is US$4,03 million. Sonoma Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.53.

SNOA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.07887.29629629631.081.261.033050311.1063314CS
40.05885.345454545451.11.291.031673361.12054553CS
12-1.1212-49.17543859652.282.880.85012330961.28611238CS
26-2.2612-66.11695906433.423.8920.85011195741.43253007CS
52-1.8412-61.373333333336.91990.85013912444.49719131CS
156-0.0612-5.016393442621.226.91990.115911255331.43592193CS
260-6.5712-85.00905562747.7313.360.115910760082.59068159CS

SNOA - Frequently Asked Questions (FAQ)

What is the current Sonoma Pharmaceuticals Inc share price?
The current share price of Sonoma Pharmaceuticals Inc is US$ 1,1588
How many Sonoma Pharmaceuticals Inc shares are in issue?
Sonoma Pharmaceuticals Inc has 3.473.554 shares in issue
What is the market cap of Sonoma Pharmaceuticals Inc?
The market capitalisation of Sonoma Pharmaceuticals Inc is USD 4,03M
What is the 1 year trading range for Sonoma Pharmaceuticals Inc share price?
Sonoma Pharmaceuticals Inc has traded in the range of US$ 0,8501 to US$ 6,9199 during the past year
What is the PE ratio of Sonoma Pharmaceuticals Inc?
The price to earnings ratio of Sonoma Pharmaceuticals Inc is -0,53
What is the cash to sales ratio of Sonoma Pharmaceuticals Inc?
The cash to sales ratio of Sonoma Pharmaceuticals Inc is 0,21
What is the registered address of Sonoma Pharmaceuticals Inc?
The registered address for Sonoma Pharmaceuticals Inc is 5445 Conestoga Court, Boulder, Colorado, 80301
What is the Sonoma Pharmaceuticals Inc website address?
The website address for Sonoma Pharmaceuticals Inc is sonomapharma.com
Which industry sector does Sonoma Pharmaceuticals Inc operate in?
Sonoma Pharmaceuticals Inc operates in the Pharmaceuticals sector

SNOA Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen